StreetAccount Summary - Trading higher/lower: EU mid-morning
DBV Technologies reports Q2 GAAP EPS ($0.31) vs year-ago ($0.34) - 10-Q (€1.78, 0.00)
StreetAccount Summary - European unusual volume traders
StreetAccount Summary - US Pre-market trading update
DBV Technologies announces first subject screened in COMFORT toddlers supplemental safety study in peanut allergic toddlers 1-3 years old (€1.50, 0.00)
Goldman Sachs reinstates DBV.FP, DBVT
StreetAccount Sector Summary - Healthcare Pre-Market
Powered by FactSet Research Systems Inc.